Adult
Conditions
Interventions
None listed
Sponsors
Yamada Bee Company, Inc.
Research Center for Immunological Analysis, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy Japanese men and women aged 20 years or older at the time of obtaining consent. 2) Subjects who have fully understood the content of the study and have given written consent of their own free will to participate in this study. 3) Subjects who have been deemed eligible by the principal investigator or sub-investigator based on a comprehensive assessment.
Exclusion criteria
Exclusion criteria: 1) Subjects with severe liver impairment, renal or heart disease, diabetes, or other serious illnesses. 2) Subjects who are receiving medication treatment or are scheduled to receive medication during the study period. 3) Subjects who have participated in other clinical trials or studies within 84 days prior to the date of consent. 4) Subjects who have donated 400 mL of blood within 84 days, 200 mL of blood within 28 days, or have undergone apheresis (plasma or platelet donation) within 14 days prior to the date of consent. 5) Pregnant or breastfeeding women, and those who wish to become pregnant during the study period. 6) Subjects who are deemed inappropriate for participation in this study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Telomere Length SIRT1mRNA Alpha-Klotho(water-soluble) 8-OHdG(urine) sIgA(Saliva) | — |
Countries
Japan
Contacts
Public ContactDaisuke Suwa
Yamada Bee Company, Inc. Institute for Bee Products & Health Science, R&D department
Outcome results
None listed